Instalab
logoInstalab

Fat Mass (Head)

A slow-moving regional reading that one small study linked to insulin, uric acid, and waist size in adults with obesity.
4.9 (4,001 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Fat Mass (Head) test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
Get a baseline on where your body stores fat now, so later scans show whether that pattern is shifting.
Watching Your Weight Creep Up
See where new pounds are landing. The head line changes little, so read it next to your trunk and visceral fat.
Told Your Insulin Is Running High
In one small study, head fat tracked insulin and uric acid in women with obesity, an exploratory add-on to those labs.
Starting a Weight Loss Medication
Repeat scans show whether you're losing fat and keeping lean tissue. Expect the head line to move the least.

About Fat Mass (Head)

If you've had a whole-body composition scan, your report probably splits your result into regions: arms, legs, trunk, and a small line for your head. That line is easy to skip. In the main adult study, more head fat went with more total and abdominal fat in adults with obesity, and in women it also went with higher fasting insulin, C-peptide, and uric acid.

This is a research-stage reading. There are no standard ranges for it, and the evidence comes from a handful of small studies. Obesity guidelines and expert body-composition standards use percent body fat, fat mass index, and visceral or abdominal fat as the metrics that guide decisions, not head fat. So this works best as one line in a larger picture you track over time. Getting a baseline now means you'll have your own numbers to compare against as the research catches up.

What the Head Region Captures

Body composition scans divide your body into zones and estimate how much of each zone is fat, lean tissue, and bone. Fat Mass (Head) is the fat portion of the head zone. It's a small number next to your trunk or legs, which is part of why it gets overlooked.

Your brain doesn't drive this number. In adults studied with MRI scans, brain size tracked lean body mass weakly and showed no relationship with how much fat a person carried.

Researchers often handle the head separately from the rest of the body. The head is one of the most stable fat stores, and its makeup changes little when people gain or lose weight, so bone and body composition studies, including children's bone studies, routinely report the whole body minus the head. Underwater weighing protocols that keep the head above water use equations built from head and face measurements to fill in the gap. Most work on head fat itself used DXA. That low-dose X-ray scan sorts tissue into fat, lean, and bone. If your result came from a different kind of device, the numbers aren't interchangeable.

Links to Insulin, Uric Acid, and HDL

The most direct evidence comes from a cross-sectional study of 66 adults with obesity in China. People with more head fat had higher BMI, larger waists and hips, a higher visceral index, and more total body fat, in both men and women. Visceral fat is packed around the abdominal organs. In women, more head fat also went with higher fasting insulin, C-peptide, and uric acid.

The same study did not find a significant direct correlation between head fat and fasting glucose, total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, or free fatty acids in either sex. So head fat isn't a stand-in for a lipid or glucose panel. The researchers did propose head-fat cutoffs for flagging low HDL and high uric acid. Those cutoffs came from one small group of a single ethnicity, measured at one point in time, so they can't show that head fat causes anything and haven't been tested in other populations.

Fat at the jaw and neck level shows a similar pattern on a different kind of scan. In 122 patients who had head and neck CT scans, simple fat measurements taken at the jaw and upper neck matched abdominal fat closely, with correlations of 0.80 to 0.92. A correlation of 1.0 would be a perfect match. Those are CT slice measurements, not DXA head fat, but they point the same way: at a single point in time, fat in the head and neck region tends to go with fat around the middle.

Who Was StudiedWhat Was ComparedWhat They Found
66 adults with obesity in ChinaDXA head fat against body size and blood markersMore head fat went with more total and abdominal fat; in women it also went with higher insulin, C-peptide, and uric acid. No link with glucose or the standard lipid panel
122 patients with head and neck CT scansFat at the jaw and neck level against abdominal fatA strong match between neck-level fat and fat around the middle
260 adults scanned with MRIBrain size against lean mass and fat massBrain size tracked lean mass weakly and had no link to fat mass

Source: Wang et al. (2014); Zopfs et al. (2022); Heymsfield et al. (2012).

What this means for you: a higher head fat reading fits with carrying more fat overall, and it's a reason to check insulin and uric acid. Because this region changes little with weight gain or loss, a jump between scans is more likely to reflect a broad change in body fat or measurement noise than anything specific to your head. On its own it doesn't diagnose anything.

Men and Women Differ

In the same study, head fat behaved differently by sex. In men it tracked neck circumference. In women it tracked trunk fat, fasting insulin, uric acid, and C-peptide.

C-peptide is released in equal amounts with insulin, so it shows how much insulin your pancreas is making. For women, fasting insulin and uric acid are the companion labs most tied to this reading in the limited evidence so far. For men, the study's link to neck size is a reminder that fat in this region tends to go with a thicker neck, which is worth noticing if you also snore or sleep poorly.

What Total Body Fat Predicts

The evidence tying fat to heart attacks, cancer, and death comes from whole-body fat measurements. No study in this area has followed head fat itself to those outcomes, so this section is about the larger number your head reading belongs to.

Pooled data from seven long-term cohorts found that more fat mass raised the risk of dying, while more lean mass lowered it. In about 356,000 UK Biobank adults, fat mass had a stronger link with cardiovascular disease than muscle mass did, though measuring it by bioimpedance didn't predict events better than BMI across the whole population. In about 454,000 adults, higher fat mass went with higher risk of obesity-related cancers, though not every cancer type moved the same way. In about 469,000 adults, a higher ratio of fat to muscle, both total and regional, went with more cardiovascular disease and death.

Where the fat sits matters. In about 468,000 UK Biobank adults, waist-to-height ratio predicted heart disease on its own, and the link between body fat percentage and heart disease ran mostly through waist size. In about 3,160 adolescents followed for nine years, higher total fat mass raised the risk of worsening insulin resistance.

What this means for you: read your head fat next to your trunk fat, visceral fat, and waist. Those are the measures these large studies tie to real risk. The head line hasn't been tested against outcomes, and it will usually move far less than your trunk or visceral fat.

Why a Single Reading Can Fool You

Body fat measurements wobble more than most people expect. When healthy adults had their body fat measured by impedance on 12 consecutive fasted days, the same person's reading varied by about 10%. On DXA, day-to-day variation was about 1% for most measurements but more than 2% for fat mass, and regional readings are less reproducible than whole-body totals. In a small region like the head, measurement noise can be as large as any real change.

  • Meals and time of day: normal daily activity and eating breakfast before a DXA scan increased measurement error, so a fasted morning scan gives you a cleaner number.
  • Positioning: pillows changed DXA soft-tissue estimates, and lying face down versus face up shifted fat and lean readings, so how your head and body are placed matters.
  • Fluid shifts: kidney disease and changes in body water biased body composition estimates, and recent illness or hard exercise can move fluid enough to show up as a change in fat or lean tissue.
  • Different machines: DXA and bioimpedance agree on average across groups but not reliably for one person, and even two DXA brands need conversion before their numbers line up. Proprietary scores from consumer devices, like a "visceral fat rating" or "metabolic age," aren't equivalent to scan-measured fat.

Scanner settings and analysis choices can also affect a result, which is another reason to compare scans from the same device.

Tracking Your Trend

Because the reading is noisy, slow to change, and has no standard range, the trend tells you more than any single scan, and your trunk fat, visceral fat, and waist will tell you more than the head line. Compare scans only when they were done under similar conditions, and treat a head change as meaningful only when those other measures move the same way.

The weight loss treatments with good evidence were measured on whole-body fat, and trials haven't reported the head region separately. Expect the head line to move the least of any region, so a nearly flat head reading during successful fat loss is normal.

What Moves This Biomarker

Evidence-backed interventions that affect your Fat Mass (Head) level

↓ Decrease
Take a GLP-1-based weight loss medication such as semaglutide or tirzepatide
These drugs can take a substantial amount of fat off your body. Randomized-trial meta-analyses show GLP-1 and GIP/GLP-1 drugs reduce total body fat, visceral fat, and subcutaneous fat. Head fat may fall only slightly, since the head is among the most stable fat stores, and trials didn't report the head region. Lean mass can also fall, so pairing treatment with resistance training and enough protein matters.
MedicationModerate Evidence
↑ Increase
Take olanzapine or another high-risk atypical antipsychotic
These drugs can add real body fat, often around the middle, which would push regional fat readings up alongside metabolic risk. In adults with first-episode psychosis, olanzapine raised body fat with a tendency toward central deposition while lean mass stayed about the same, along with higher insulin and triglycerides. If you take one of these and see fat climbing on your scans, bring the trend to your prescriber; don't stop the drug on your own.
MedicationModerate Evidence
↑ Increase
Take alectinib for ALK-positive lung cancer
This cancer drug can cause substantial fat gain, especially around the abdomen, sometimes alongside muscle loss. Patients on alectinib developed increased waist circumference, visceral fat, and subcutaneous fat over time, so rising fat on your scans during treatment is worth raising with your oncology team. Head fat was not measured separately.
MedicationModerate Evidence
↓ Decrease
Combine calorie restriction with resistance training or mixed exercise
Eating less while lifting weights is one of the best-supported lifestyle routes to losing fat while keeping more lean tissue. Network meta-analyses of randomized trials ranked calorie restriction plus exercise as a strong strategy for cutting fat percentage while preserving lean mass, and resistance exercise during dieting increased fat loss and protected lean tissue. These trials measured whole-body fat, not the head region, which typically changes little with weight loss.
ExerciseModest Evidence

Frequently Asked Questions

References

34 studies
  1. Xingchun Wang, Huan Liu, Yue-ye Huang, Hang Sun, L. Bu, S. QuLipids in Health and Disease2014
  2. D. Zopfs, D. Pinto Dos Santos, J. Kottlors, R. Reimer, S. Lennartz, Roman Kloeckner, M. Schlaak, S. Theurich, C. Kabbasch, M. Schlamann, N. Grosse HokampEuropean Radiology2022
  3. Emma M. Clark, a. R. Ness, J. TobiasThe Journal of Clinical Endocrinology and Metabolism2006
  4. J. Tesch, P. Papadopoulos, F. Dolgener, G. TinsleyJournal of Functional Morphology and Kinesiology2022
  5. S. Heymsfield, M. Muller, a. Bosy-westphal, Diana M. Thomas, W. ShenAmerican Journal of Human Biology2012